| Source HCPCS Code |
|
Target NDC Code |
J0217
INJECTION, VELMANASE ALFA-TYCV, 1 MG
|
⇄
|
10122-0180-02
LAMZEDE (PF,LYOPHILIZED) 10 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J0217
Inj velmanase alfa-tycv 1 mg
|
⇄
|
10122-0180-02
Lamzede
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0217
Inj velmanase alfa-tycv 1 mg
|
⇄
|
10122-0180-05
Lamzede
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0217
Inj velmanase alfa-tycv 1 mg
|
⇄
|
10122-0180-10
Lamzede
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|